HebeCell

About:

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

Website: https://hebecellcorp.com

Top Investors: Jacobio Pharmaceuticals, Aceso Biotech Venture Fund

Description:

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.

Total Funding Amount:

$63M

Headquarters Location:

Natick, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)hebecell.com

Founders:

Allen Feng

Number of Employees:

11-50

Last Funding Date:

2021-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai